By-health Co. Ltd. said its fourth-quarter normalized net income amounted to 3 fen per share, compared with the S&P Capital IQ consensus estimate of 5 fen per share.

The per-share result swung to a profit from the prior-year loss of 1 fen.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 36.8 million yuan, compared with a loss of 11.0 million yuan in the year-earlier period.

The normalized profit margin rose to 5.1% from negative 3.4% in the year-earlier period.

Total revenue rose 51.7% year over year to 485.4 million yuan from 320.0 million yuan, and total operating expenses rose 41.9% year over year to 468.3 million yuan from 329.9 million yuan.

Reported net income grew on an annual basis to 52.8 million yuan, or 3 fen per share, from 21.2 million yuan, or 2 fen per share.

For the year, the company's normalized net income totaled 33 fen per share, compared with the S&P Capital IQ consensus normalized EPS estimate of 45 fen.

EPS rose 23.5% from 26 fen in the prior year.

Normalized net income was 465.7 million yuan, an increase of 34.5% from 346.3 million yuan in the prior year.

Full-year total revenue grew 32.9% from the prior-year period to 2.27 billion yuan from 1.70 billion yuan, and total operating expenses increased 36.2% year over year to 1.63 billion yuan from 1.19 billion yuan.

The company said reported net income grew 27.5% on an annual basis to 637.5 million yuan, or 44 fen per share, in the full year, from 499.9 million yuan, or 38 fen per share.

As of Feb. 26, US$1 was equivalent to 6.54 yuan.